Oruka Therapeutics (ORKA) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | -87.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.69% |
| Dec 31, 2025 | 675.31% |
| Sep 30, 2025 | -77.93% |
| Jun 30, 2025 | 96.48% |
| Mar 31, 2025 | 927.31% |
| Dec 31, 2024 | 64.50% |
| Sep 30, 2024 | 947.94% |
| Jun 30, 2024 | -17.12% |
| Mar 31, 2024 | -12.11% |
| Dec 31, 2023 | -11.81% |
| Sep 30, 2023 | -12.41% |
| Jun 30, 2023 | -13.53% |
| Mar 31, 2023 | -16.73% |
| Dec 31, 2022 | -20.45% |
| Sep 30, 2022 | -24.65% |
| Jun 30, 2022 | -26.52% |
| Mar 31, 2022 | -26.70% |
| Dec 31, 2021 | 8.74% |
| Sep 30, 2021 | 14.13% |
| Jun 30, 2021 | 472.38% |
| Mar 31, 2021 | 902.89% |
| Dec 31, 2020 | 486.76% |
| Sep 30, 2020 | 429.76% |
| Jun 30, 2020 | 10.79% |
| Mar 31, 2020 | -16.64% |
| Dec 31, 2019 | 26.56% |
| Sep 30, 2019 | 19.40% |
| Jun 30, 2019 | 3.44% |
| Mar 31, 2019 | -33.81% |
| Dec 31, 2018 | -24.06% |
| Sep 30, 2018 | -0.79% |
| Jun 30, 2018 | 5.87% |
| Mar 31, 2018 | 96.05% |
| Dec 31, 2017 | 17.58% |
| Sep 30, 2017 | 0.58% |
| Jun 30, 2017 | -36.71% |
| Mar 31, 2017 | -79.24% |
| Dec 31, 2016 | -80.93% |
| Sep 30, 2016 | -80.49% |
| Jun 30, 2016 | -67.38% |
| Mar 31, 2016 | 143.90% |
| Dec 31, 2015 | 152.72% |
| Sep 30, 2015 | 140.49% |
| Jun 30, 2015 | 127.52% |
| Mar 31, 2015 | -42.53% |
| Dec 31, 2014 | -8.37% |
| Sep 30, 2014 | -7.42% |
| Jun 30, 2014 | -4.89% |
| Mar 31, 2014 | 499.43% |
| Dec 31, 2013 | 473.84% |
| Sep 30, 2013 | 504.74% |
| Jun 30, 2013 | 540.29% |
| Mar 31, 2013 | -16.32% |
| Dec 31, 2012 | -50.87% |
| Sep 30, 2012 | -46.40% |
| Jun 30, 2012 | -57.36% |
| Mar 31, 2012 | -16.87% |
| Dec 31, 2011 | -15.40% |
| Sep 30, 2011 | -27.30% |
| Jun 30, 2011 | -24.75% |